Drug intelligence / Profile preview

Aquamin F

Development stage
Phase 2
Lead developer
Marigot
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Aquamin F** is a seaweed-derived multi-mineral nutraceutical developed by Marigot for symptomatic knee osteoarthritis. It is produced from calcified red algae and provides calcium, magnesium, and numerous trace minerals; it is not a conventional single-molecule pharmaceutical and has no established discrete molecular target. Its proposed activity is nutritional mineral repletion and support of joint function, with possible indirect effects on inflammatory processes and musculoskeletal health. In randomized placebo-controlled studies in moderate-to-severe knee osteoarthritis, oral Aquamin F at 2,400 mg/day for up to 12 weeks was evaluated for effects on pain, stiffness, mobility, walking distance, range of motion, and NSAID-use reduction. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC2642861/))

Brand names
Aquamin F
Other names
marine multimineral complexmarine minerals from Lithothamnion sp.calcified Lithothamnion tophiformenatural seaweed derived mineral supplementAquaMin-F

Beyond the preview

Go deeper on Aquamin F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquamin F.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call